6-o-veratroyl catalpol has been researched along with phorbolol myristate acetate in 1 studies
Studies (6-o-veratroyl catalpol) | Trials (6-o-veratroyl catalpol) | Recent Studies (post-2010) (6-o-veratroyl catalpol) | Studies (phorbolol myristate acetate) | Trials (phorbolol myristate acetate) | Recent Studies (post-2010) (phorbolol myristate acetate) |
---|---|---|---|---|---|
6 | 0 | 5 | 314 | 2 | 127 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, MS; Le, MQ; Oh, SR; Ryu, HW; Song, YS; Yoon, DY | 1 |
1 other study(ies) available for 6-o-veratroyl catalpol and phorbolol myristate acetate
Article | Year |
---|---|
6-O-Veratroyl catalpol suppresses pro-inflammatory cytokines via regulation of extracellular signal-regulated kinase and nuclear factor-κB in human monocytic cells.
Topics: Active Transport, Cell Nucleus; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Tumor; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Humans; Interleukin-1beta; Iridoids; Macrophage Activation; Macrophages; MAP Kinase Signaling System; Monocytes; NF-kappa B; Plant Leaves; Plant Stems; Protein Kinase C; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Veronica | 2015 |